Skip to content

Our Devices

Introducing TAP® Micro and TAP® Micro Select

Our devices produce high-quality, whole blood samples at consistently high volumes of up to 900µL through virtually painless capillary blood collection, making them ideal for decentralized clinical trials, wellness testing, and clinical-grade blood sampling. Remote blood collection allows the opportunity to replace traditional phlebotomist-conducted venous blood collection or painful fingerstick tests in at home blood collection applications.

  • Discover how the proprietary HALO™ Technology enables virtually painless blood draws Learn More

TAP® Micro Select

TAP® Micro Select uses the same bladeless blood draw technology as TAP® Micro and takes the pain out of blood collection in decentralized clinical trials as well as health and wellness testing. Using HALO™ technology, a bladeless microneedle array, TAP® Micro Select enables virtually painless, large-volume collection of up to 900µL of whole, capillary high-quality blood.

  • FDA 510(k) Cleared
  • CE Marked
  • HALO™ Technology, bladeless microneedle array
  • Discover TAP® Micro Select’s expanded regulatory approval with award of CE Mark Read Article
Adhesive Liner
Tube Port

TAP® Micro

TAP® Micro offers an easy-to-remove detachable sample tube, with capillary blood collection volumes of as much as 900µL, and multiple sample tube type choices to meet customer needs. TAP® Micro devices have been successfully employed by hospitals and medical professionals for investigational use to conduct remote blood collection on a wide range of patients spanning ages and conditions, validating its flexibility and effectiveness in the field.

  • CE Marked
  • Investigational Use Only in the US
  • Pre-attached collection tubes
  • HALO™ Technology bladeless microneedle array
  • See how Columbia University is utilizing TAP® Technology to improve patient experiences at their fertility clinic Read Article
Adhesive Liner
Tube Cap
Product Guides
Learn more about TAP® Micro and TAP® Micro Select Explore Product Guides
Product Videos
See how our TAP® devices leverage the HALO™ Technology Explore Product Videos

Our Results Speak for Themselves

Up to 900µL of Whole Capillary Blood

Our HALO™ Technology enables patients to collect up to 900µL of blood, accommodating a broad range of standard blood tests1

Up to 99% Collection Success Rate

Our devices are end-user preferred, virtually painless, and yield up to a 99% collection success rate2

200% Increase in Patient Retention/Completion Rates in Clinical Trials

Significantly higher completion rates in clinical trials when compared to fingerstick3

98% of Patients Would Repeat Self-Collection

When asked if they would repeat their self-collection experience with TAP® Micro, 98% of patient respondents responded “yes”4

High Venous Concordance

For broad-based tests, such as cholesterol, capillary blood samples collected in both an assisted and self-collection setting have high concordance with venous blood5

Drawing Blood Doesn’t Have to Be a Pain in the Arm

We offer customizable sample management services, including kitting, fulfillment, and sample tracking from the end user to any central lab.

  • Interested in learning more about our TAP® devices and service offerings? Get in touch with our experts. Contact Us

Latest Research and Highlights

Discover the latest studies and reports published on our devices and solutions

View All
  • July 1, 2024
    Feasibility, reliability and satisfaction of (automated) capillary carcinoembryonic antigen measurements for future home-based blood sampling: the prospective CASA-I study
    Colorectal Disease

    Feasibility of home-based capillary sampling of colorectal cancer marker CEA was demonstrated. TAP was found to be “the most reliable method and is preferred by patients over venipuncture and lancet sampling.” (Erasmus MC)

    Read More
  • April 11, 2024
    Evaluation of a hybrid telehealth care pathway for patients with axial spondyloarthritis including self-sampling at home: results of a longitudinal proof-of-concept mixed-methods study (TeleSpactive)
    Rheumatology International

    TAP was employed to demonstrate the feasibility, high patient acceptance, and overall potential of a scalable axSpA hybrid telehealth care pathway.

    Read More
  • February 19, 2024
    Placental transfer dynamics and durability of maternal COVID-19 vaccine-induced antibodies in infants

    TAP devices used to collect blood samples from 2-month-old and 12-month-old infants in Sars-CoV-2 infection risk study

    Read More
View All
  1. Citation: Citation: Internal data.
  2. Citation: Citation: This is a customer-reported statistic.
  3. Citation: Citation: This is a customer-reported statistic.
  4. Citation: Internal data.
  5. Citation: Collier, B. B., Brandon, W. C., Chappell, M. R., Kovach, P. M. & Grant, R. P. Maximizing Microsampling: Measurement of Comprehensive Metabolic and Lipid Panels Using a Novel Capillary Blood Collection Device. J. Appl. Lab. Med. jfad066 (2023) doi:10.1093/jalm/jfad066.